News

The funding will support the launch of the VERITAS trial while strengthening the company's clinical and regulatory ...
Field Medical announced today that it has closed a Series B funding round worth proceeds totaling $35 million.
Field Medical has generated another $35 million in venture capital funding for its cardiac pulsed field ablation system to support the launch of a pivotal trial. | The series B financing comes quickly ...
BioStar Capital and Cue Growth co-lead financing to accelerate pivotal trial readiness and expand the ventricular tachycardia ...
Scientist and teacher releases book summarizing his field of research from the last 25 years BALTIMORE, Nov. 4, 2024 /PRNewswire-PRWeb/ -- Author Victor Frenkel, PhD, has published his new popular ...
Most gene therapies being studied for eye diseases are in earlier phases of development, and a third of the gene therapies ...
Researchers have developed a gene therapy technology that uses magnetic fields to switch groups of neurons on and off, controlling brain circuits affected by Parkinson’s disease. In addition to ...
Javid A, Biswas R, Ilham S, Chukwu C, Yang Y, Chen H, and Kiani M. A modular 16-channel high-voltage ultrasound phased array system for therapeutic medical applications. Neuroelectronics 2024(1):0004, ...
--PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy on gait deficit improvement in people with Multiple Sclerosis ...
Helius Medical Technologies, Inc. (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation ...
In the interdisciplinary field of medicine and materials science, a recent breakthrough by Professor Jianlin Shi's team is revolutionizing antibacterial therapy. They have successfully developed a ...
NEWTOWN, Pa., June 04, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation ...